Tag: Mergers & Acquisitions
-

Warner Bros. Discovery Board Recommends Shareholders Reject Paramount Tender Offer in Favor of Netflix Merger
Overview The Warner Bros. Discovery (WBD) board has unanimously advised shareholders to reject Paramount Global’s tender offer. The recommendation reinforces WBD’s commitment to its previously announced Netflix combination, which the board believes offers superior value and greater certainty for shareholders than the Paramount proposal. Why the Paramount Offer Is Viewed as Inadequate In its formal…
-

Aker ASA’s Mainstream Renewable Deal Backfires as €1.2bn Losses Hit Norwegian Giant
Overview: Aker ASA’s Ambitious Move into Mainstream Renewable Power Norway’s industrial heavyweight Aker ASA has long been known for turning engineering heritage into strategic industrial plays. The January 2021 acquisition of Eddie O’Connor’s Mainstream Renewable Power marked a bold foray into the global green power sector, aiming to accelerate Aker’s transformation into a major force…
-

Paramount, Comcast, and Netflix Bid on Warner Bros. Discovery: Market Shakeup Ahead
Industry Shakeup: Major Bidders Circle Warner Bros. Discovery The media landscape is entering a new phase of consolidation as Paramount Global, Comcast, and Netflix have all submitted bids to acquire Warner Bros. Discovery, according to multiple industry sources. The potential deal could reshape ownership of some of the world’s largest content catalogs and streaming platforms,…
-

IIL Acquires Novartis Pharma Pakistan — CCP Approval
Regulatory Green Light: CCP Approves the IIL–Novartis Pharma Pakistan Deal The Competition Commission of Pakistan (CCP) has given its approval for International Investment Limited (IIL) to acquire Novartis Pharma (Pakistan) Limited. This decision marks a significant milestone in Pakistan’s pharmaceutical investment landscape, signaling a careful yet optimistic stance toward consolidation in the sector. Under the…
-

Pakistan’s CCP Approves International Investment to Acquire Novartis Pharma Pakistan
Pakistan’s Competition Commission Grants Approval for Acquisition The Competition Commission of Pakistan (CCP) has given the green light for International Investment Limited (IIL) to acquire Novartis Pharma (Pakistan) Limited. The decision comes after the CCP completed its Phase-I competition assessment under Section 11 of the Competition Act, signaling a structured review of how the deal…
-

Pakistan Grants Phase-I Approval for International Investment Limited to Acquire Novartis Pharma Pakistan
Regulatory Approval Marks Milestone in Pakistan’s Pharma Sector The Competition Commission of Pakistan (CCP) has granted Phase-I clearance for the acquisition of Novartis Pharma (Pakistan) Limited by International Investment Limited (IIL). This decision, announced after a thorough competition assessment under Section 11, signals a significant development for the pharmaceutical landscape in Pakistan and the broader…
-

Kenvue and Kimberly-Clark Merge in $48.7B Tylenol Maker Deal
Overview: A Mega-Merger in the Consumer Products Arena In a deal valued at approximately $48.7 billion, Kimberly-Clark, the maker of Huggies, will acquire Kenvue, the parent company of Tylenol. The proposed transaction signals a bold consolidation move in the consumer packaged goods sector, combining a leading diaper brand with a broad portfolio of health-focused consumer…

